Who is sponsoring NCT05058222?

NCT05058222 is sponsored by Riphah International University.

What drugs are being tested in NCT05058222?

Interventions in NCT05058222: Deep Breathing Exercise after every 3hrs, each session consists of 10 deep breaths Exercise, Deep Breathing Exercise after every 3hrs, each session consist of 30 deep breaths Exercise.

What condition does NCT05058222 study?

NCT05058222 studies Coronary Artery Bypass Graft.

Is NCT05058222 still recruiting?

NCT05058222 is currently completed. Last updated 11 January 2022.

Last reviewed 2022-01-11 · How we verify

NCT05058222

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Deep Breathing Exercises on Post Operative Sleep Duration

Completed NA Last updated 11 January 2022

What this trial tests

NA trial testing Deep Breathing Exercise after every 3hrs, each session consists of 10 deep breaths Exercise in Coronary Artery Bypass Graft in 28 participants. Completed in 30 December 2021.

Timeline

15 October 2020

Primary endpoint
30 December 2021

30 December 2021

Quick facts

Lead sponsor	Riphah International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	28
Start date	15 October 2020
Primary completion	30 December 2021
Estimated completion	30 December 2021
Sites	1 location across Pakistan

Drugs / interventions tested

Deep Breathing Exercise after every 3hrs, each session consists of 10 deep breaths Exercise
Deep Breathing Exercise after every 3hrs, each session consist of 30 deep breaths Exercise

Conditions studied

Coronary Artery Bypass Graft — all drugs for Coronary Artery Bypass Graft →

Sponsor

Riphah International University

Who can join

Adults 30 to 69, any sex, with Coronary Artery Bypass Graft. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will provide the evidence that during the postoperative period deep breathing exercise combined with physical training can positively influence the sleep duration and quality. This study will provide the evidence that during the postoperative period deep breathing exercise combined with physical training can positively influence the sleep duration and quality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Coronary Artery Bypass Graft

Currently open trials in the same condition.

NCT06602336 — A Single Centre Study Comparing Continuous Interstitial Fluid Lactate Detection to Standard Measurements of Lactate in P · NA · recruiting
NCT06800430 — Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery · recruiting
NCT06603961 — Prevention of Edema After Coronary Artery Bypass Graft by Customized Pressure-guided Elastic Bandages · NA · recruiting
NCT06705556 — Effect of Active Cycle of Breathing Technique as Add on to Routine Chest Physical Therapy on Respiratory Parameters in C · NA · active not recruiting

Other Riphah International University trials

Trials by the same sponsor.

NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05058222 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Riphah International University
Last refreshed: 11 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05058222.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing